Schott Pharma AG KGaAFRA:1SX -0.98%64 Dividend Yield % is 1.11% as of Jun. 27, 2026, which is 76% above its 10-year median of 0.63. GuruFocus rates FRA:1SX with a GF Score™ of 64/100 and a GF Value™ of €6.56. The stock has 2 warning signs investors should review. Among 328 Medical Devices & Instruments companies, Schott Pharma AG KGaA ranks worse than 72.26% on this metric.
As of today (2026-06-27), the Trailing Annual Dividend Yield of Schott Pharma AG KGaA is 1.11%.
The historical rank and industry rank for Schott Pharma AG KGaA's Dividend Yield % or its related term are showing as below:
FRA:1SX'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.38 Med: 0.63 Max: 1.31
Current: 1.11
During the past 6 years, the highest Dividend Yield of Schott Pharma AG KGaA was 1.31%. The lowest was 0.38%. And the median was 0.63%.
FRA:1SX's Dividend Yield % is ranked worse than 72.26% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 2
vs FRA:1SX: 1.11
During the past 12 months, Schott Pharma AG KGaA's average Dividends Per Share Growth Rate was 12.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Schott Pharma AG KGaA (FRA:1SX) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Schott Pharma AG KGaA Dividend Yield % Related Terms
Schott Pharma AG KGaA Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Schott Pharma AG KGaA's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1SX vs ISRG, BDX, MDLN: Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Schott Pharma AG KGaA Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Schott Pharma AG KGaA's Dividend Yield % falls into.
Schott Pharma AG KGaA Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Schott Pharma AG KGaA Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.052957
2026-02-05
2026-02-05
2026-02-23
Cash Dividend
annually
USD:EUR 0.851000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Schott Pharma AG KGaA's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Schott Pharma AG KGaA (FRA:1SX) has a Dividend Yield % of 1.11% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Schott Pharma AG KGaA and its competitors. This is 76% above median its historical median of 0.63. Over the past decade, Schott Pharma AG KGaA's Dividend Yield % has ranged from 0.38 to 1.31. According to the industry distribution chart, Schott Pharma AG KGaA ranks #237 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 72.3%.
Is Schott Pharma AG KGaA's Dividend Yield % too high?
Schott Pharma AG KGaA's current Dividend Yield % of 1.11% is 76% above median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 1.31. The Medical Devices & Instruments industry median Dividend Yield % is 2.00. Schott Pharma AG KGaA's value of 1.11% is 44.5% below this industry median. Based on the distribution chart, Schott Pharma AG KGaA ranks #237 out of 328 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Schott Pharma AG KGaA has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Schott Pharma AG KGaA ranks #237 out of 328 companies for Dividend Yield %. This places Schott Pharma AG KGaA in the lower half of its industry. The industry median Dividend Yield % is 2.00. Schott Pharma AG KGaA's value of 1.11% is 44.5% below this benchmark. Historically, Schott Pharma AG KGaA's own Dividend Yield % has ranged from 0.38 to 1.31 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 2.00, Schott Pharma AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 2.00, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Schott Pharma AG KGaA's current Dividend Yield % of 1.11% is 44.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Schott Pharma AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Schott Pharma AG KGaA's current Dividend Yield % is 1.11%, which is 76% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (FRA:1SX) has a current Dividend Yield % of 1.11%. The stock's GF Value™ is €6.56, compared to a current price of €4.04 — trading 38.4% below its estimated fair value. The current Dividend Yield % is 1.11%, which is 76% above median its 10-year median of 0.63 and 44.5% below the Medical Devices & Instruments industry median of 2.00. Schott Pharma AG KGaA's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Schott Pharma AG KGaA (FRA:1SX), the current Dividend Yield % is 1.11% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schott Pharma AG KGaA (FRA:1SX) Overvalued in 2026?
Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued.
The current stock price of €4.04 is trading 38.4% below its estimated GF Value™ of €6.56.
Key valuation signals for FRA:1SX:
Dividend Yield %: 1.11% (76% above median its 10-year median of 0.63)
GF Value™: €6.56 vs. price of €4.04 (38.4% below fair value)
Industry Position: 44.5% below the Medical Devices & Instruments median (#237 of 328)
No single metric tells the full story. See the FRA:1SX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
64GF Score
Get the complete analysis for FRA:1SX
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1SX has been successfully added to your 
